Megan D. Bailey, a former officer at Labcorp Holdings Inc., has filed a notice to sell 3,035 shares of the company’s common stock. This transaction is significant as it represents a value of approximately $1.1 million, following her exercise of stock options on November 4, 2026.

This filing is noteworthy not only for Bailey but also for Labcorp, which operates in the medical laboratory services sector. The sale reflects ongoing stock movements within the industry as companies like Labcorp continue to adapt to evolving market demands.

Background

Labcorp Holdings Inc. is a prominent player in the medical laboratories industry, classified under the SIC code 8071. The company, which has undergone name changes in the past, is headquartered in Burlington, North Carolina. Labcorp is known for its extensive range of laboratory services and diagnostic solutions.

What the Filing Says

The SEC filing indicates that Bailey exercised stock options to acquire the shares she intends to sell. The filing states, "The nature of acquisition transaction is stock option exercise," and lists Fidelity Brokerage Services LLC as the broker handling the transaction.

Impact

This sale may impact Labcorp’s stock dynamics, particularly as it reflects the financial decisions of former executives. With 81,200,000 shares outstanding, the sale of 3,035 shares is a small fraction but could signal broader trends in executive stock movements within the company.

What's Next

The filing does not say what happens next.